The new 2,000 square foot lab at StartX headquarters in Palo Alto, CA has 20 bench seats and will house a mix of StartX Med participants and tenants not affiliated with the accelerator program.
Photo courtesy of StartX
The lab is small but has standard equipment including four ventilation hoods, PCR machines, an autoclave, and a 3-D printer.
Photo courtesy of StartX
Robinson (left), director of R&D of the lab's first tenant, Nirmidas Biotech, talks to StartX Med founder Lee.
Photo courtesy of StartX
Nirmidas director of R&D Joshua Robinson (left) and CEO Meijie Tang at the company's two-seat workspace in the lab.
Photo by Alex Lash
Nirmidas's Joshua Robinson shows one of Nirmidas's microarray slides, coated with gold nano-film, side by side with a normal glass slide.
Photo by Alex Lash
Nirmidas Biotech moved from the QB3@953 incubator in San Francisco to StartX, which is a ten-minute bike ride from its scientific founder's Stanford lab in the Keck Science Building.
The Palo Alto, CA-based nonprofit tech accelerator StartX has already grown a biomedical arm, called StartX Med. Now it’s adding laboratory space to its new headquarters in a joint effort with Bay Area incubator network and seed funder QB3.
The new wet lab, dubbed StartX-QB3 Labs, is officially open this week and adds to the growing swath of Bay Area biomedical real estate that caters to tiny startups in need of cheap, flexible research space.
The new facility is relatively small at just 2,000 square feet. (Compare that to QB3’s “953” incubator in San Francisco, with 23,700 square feet.) But it’s got standard equipment, including ventilator hoods, PCR machines, a light microscope, an autoclave to sterilize tools, and refrigeration for biological samples, plus a hardware prototype room with a 3-D printer.
The 20 bench spaces are theoretically enough to house 20 one-person startups. More likely, a few StartX Med participants will occupy the lab at any one time, with the rest of the benches filled by rent-paying scientist-entrepreneurs not affiliated with the StartX accelerator program.
“In all cases, we hope to accelerate the development of medical, engineering, chemistry, and hardware companies so that they can demonstrate proof of concept and reach their Series A,” says StartX Med founder Andrew Lee, a Stanford University MD/PhD candidate whose academic career is on hiatus as he runs the accelerator offshoot as well as his own biotech startup, Stem Cell Theranostics.
Another highly touted Bay Area accelerator, Y Combinator, has also embraced biotech, showcasing its first class at last week’s Demo Day. But Y Combinator doesn’t have physical lab space to offer its life science participants. (Another difference: StartX, unlike Y Combinator, does not take an equity stake in its participant companies.)
To get a leg up on the lab front, StartX has joined forces with San Francisco-based QB3 (officially the California Institute for Quantitative Biosciences). Originally a product of the University of California’s three Bay Area campuses, the group has become a local life science innovation promoter, renting lab space, offering classes and mentorship, and overseeing a small venture fund.
QB3 will operate the new lab, a small irony in the lore of Bay Area rivalries, with the University of California and Stanford at odds, athletically and culturally, for more than a century.
The StartX program was founded in 2009 by Stanford students and offers tech participants three-month sessions that culminate in a showcase. StartX Med sessions run for six months. (Here’s our slide show from last year’s StartX Demo Day; the next one is September 16 to showcase its 33 summer session companies, 15 of which are StartX Med.)
But StartX didn’t have formal ties to Stanford until last year, when the school and affiliated hospital pledged $3.6 million over three years to the nonprofit, bringing its total funding … Next Page »
By posting a comment, you agree to our terms and conditions.
Sponsored · Video
A Fireside Chat with Fish & Richardson Principal Teresa Lavoie
Fish & RichardsonSponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
PRA Health SciencesSponsored · Whitepaper
What the most successful life sciences fundraising pitch decks all have in common
Brex© 2007-2021, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
How can I get samples of my Mitochondria cells quanity and quality of the Mitochondria CELL’S THANKS Erick Garcia Capricornsystems